Josephine has over 20 years’ experience in global hedge fund, family office and asset management including over 15 years as an investor in listed, pre-IPO and early-stage healthcare companies across Asia. She specialises in strategic partnerships, operations, market positioning and regulatory affairs across the Pan Asia healthcare landscape. She is Chief Investment Officer of Sapere Capital Management, an asset management platform which provides global asset allocation and investment solutions focused on capital appreciation and wealth preservation for families, corporates and entrepreneurs. Previously, she was the Head of Asia Absolute Return and Alternative Strategies at UBP, Managing Partner of Light & Salt Capital Management, Regional Portfolio Manager at Robeco Hong Kong and Yu Ming Investments, and General Partner at LR Global Partners in New York. Josephine is also the founder of Aionious Management Limited, an investment company that provides business development and commercialisation strategies mainly on innovative industries; she is an independent investment committee member at Biocurate, an non-executive director at RAWS-Tech and a former Board member at Mydecine Innovations Group.
Josephine Wu
